CAS: 113806-05-6; (Z)-2-(11-(3-(Dimethylamino)Propylidene)-6,11-Dihydrodibenzo[b,E]Oxepin-2-yl)Acetic Acid

上下游产品

CAS号113806-01-2 (Z)-11-[3-(dime... | CAS号1123338-92-0 11-[(Z)-3-(dime... | CAS号1253179-74-6 (Z)-11-[3-(dime... | CAS号19070-16-7 magnesium,N,N-d... | CAS号140462-76-6 盐酸奥洛他定 | CAS号1376615-97-2 奥洛他定甲醛

奥洛他定丁酯置于potassium Hydroxide,Sodium Hydroxide,盐酸体系中,用 水,甲苯,丙酮 用作溶剂,化学反应 4.0H,反应生成奥洛他定
参考文献: Process For The Preparation Of Olopatadine[fr] Procédé De Préparation De L'Olopatadine
标题: Process For The Preparation Of Olopatadine[fr] Procédé De Préparation De L'Olopatadine

专利信息

专利号:US-9562030-B2
优先权日:2013-03-19
标题:Process for the synthesis of olopatadine
发明人：CHAVAN SUBHASH PRATAPRAO; LASONKAR PRADEEP BHASKARRAO
权利人:COUNCIL SCIENT IND RES
摘要:The present invention provides a process for the synthesis of olopatadine. Further, the invention discloses a process that results in improved yield of the desired Z isomer.

专利号:WO-2023075715-A1
优先权日:2021-10-26
标题 :A pharmaceutical formulation including leukotriene receptor antagonists and/or leukotriene synthesis inhibitors combined with non-steroidal anti-inflammatory drugs (nsaids)
发明人：OYTUN FARUK; CAN EFE
权利人:VSY BIYOTEKNOLOJI VE ILAC SANAYI ANONIM SIRKETI
摘要:This invention is related to a pharmaceutical formulation including Leukotriene receptor antagonists and/or Leukotriene synthesis inhibitors combined with non-steroidal anti-inflammatory drugs (NSAIDs) and antihistamines in ocular diseases and in inflammatory and allergic diseases for systemic and topical use. The objective of this invention is to create a novel formulation to be effective as much as steroids while having significantly less side effects for long-term use in treating ocular diseases, inflammatory and allergic diseases. In other words our aim is to achieve the inhibition of pro-inflammatory mediators (prostaglandins, thromboxane, histamine and leukotrienes) as much as steroids do with a safer combination.

专利号:US-2016280677-A1
优先权日:2013-03-19
标 题:A process for the synthesis of olopatadine

专利号:WO-2014147647-A1
优先权日:2013-03-19
标 题:A process for the synthesis of olopatadine

专利号:US-2013030282-A1
优先权日:2011-07-18
标题:Synthesis and characterization of near ir fluorescent magnetic and non-magnetic albumin nanoparticles for biomedical applications
发明人：MARGEL SHLOMO; COHEN SARIT; SALKMON ENAV COREM; PELLACH MICHAL
权利人:UNIV BAR ILAN; MARGEL SHLOMO; COHEN SARIT; SALKMON ENAV COREM; PELLACH MICHAL
摘要:The present invention discloses Near Infrared (NIR) fluorescent albumin nanoparticles having a structure selected from a core structure or a core-shell structure. Also disclosed are a process of preparing these NIR fluorescent albumin nanoparticles, and a method of in vivo detection of pathologies, in particular cancer pathology, by using administering these NIR fluorescent albumin nanoparticles to a patient.

专利号:US-2007148246-A1
优先权日:2005-08-11
标题:Nucleic Acid-Based Matrixes
发明人：LUO DAN; LI YOUGEN
权利人:LUO DAN; LI YOUGEN
摘要:Various nucleic acid-based matrixes are provided, comprising nucleic acid monomers as building blocks, as well as nucleic acids encoding proteins, so as to produce novel biomaterials. Methods of utilizing such biomaterials include delivery of biologically active agents, cell and tissue culture, and cell-free protein synthesis.